Skip to main content

Table 1 Baseline characteristics at the time of diagnosis of cirrhosis in Halland, 2011–2018

From: Incidence, aetiology and related comorbidities of cirrhosis: a Swedish population-based cohort study

 

Alcohol

HCV

Cryptogenic

NAFLD

PBC

AIH

Other causes

Overall

Overall, n (%)

302 (50.5)

80 (13.4)

87 (14.5)

34 (5.7)

31 (5.2)

30 (5.0)

34 (5.7)

598 (100)

Male, n (%)

212 (70)

55 (69)

59 (68)

19 (56)

5 (16)

6 (20)

24 (71)

380 (64)

Female, n (%)

90 (30)

25 (31)

28 (32)

15 (44)

26 (84)

24 (80)

10 (29)

218 (36)

Median age (years) (10–90 percentile)

65 (52–76)

57 (46–67)

76 (63–88)

75 (62–86)

72 (58–81)

69 (46–85)

64 (30–83)

66 (50–81)

Comorbidities, n (%)

 Hypertension

96 (32)

17 (21)

32 (37)

23 (68)

12 (39)

7 (23)

9 (27)

196 (33)

 Ischaemic heart disease

59 (20)

4 (5)

27 (31)

11 (32)

7 (23)

2 (6.7)

4 (12)

114 (19)

 Chronic heart failure

37 (12)

2 (2.5)

35 (40)

8 (24)

1 (3.2)

0 (0)

3 (8.8)

86 (14)

 Type 2 diabetes

78 (26)

6 (21)

37 (43)

18 (53)

9 (29)

4 (13)

8 (24)

171 (29)

 Obesity a

81 (27)

18 (23)

10 (11)

24 (70)

4 (13)

5 (17)

1 (2.9)

143 (24)

Severity, n (%)b

 MELD (median)

14

9

11.5

9

6

10

10

11

 MELD < 10

70 (23)

49 (61)

30 (34)

16 (47)

23 (74)

14 (47)

14 (41)

216 (36)

 MELD 10–15

84 (28)

11 (15)

19 (22)

6 (18)

4 (13)

6 (20)

11 (32)

142 (24)

 MELD ≥15

140 (46)

18 (23)

27 (31)

9 (26)

1 (3.2)

9 (30)

6 (18)

210 (35)

 Child-Pugh A

80 (26)

48 (60)

19 (22)

16 (47)

24 (77)

15 (50)

16 (47)

217 (36)

 Child-Pugh B

122 (40)

21 (26)

47 (54)

12 (35)

4 (13)

10 (33)

12 (35)

228 (38)

 Child-Pugh C

91 (30)

11 (15)

10 (11)

3 (8.8)

0 (0)

4 (13)

3 (8.8)

122 (20)

 Baveno IV, 1–2

121 (40)

53 (66)

33 (38)

25 (74)

28 (90)

22 (73)

23 (68)

305 (51)

 Baveno IV, 3–4

181 (60)

27 (34)

54 (62)

9 (26)

3 (10)

8 (27)

11 (32)

292 (49)

Complications, n (%)

 Any complication

227 (75)

44 (55)

74 (85)

23 (68)

7 (21)

15 (50)

19 (56)

409 (68)

 Ascites

175 (58)

24 (30)

52 (60)

8 (24)

3 (10)

8 (27)

10 (29)

280 (47)

 Oesophageal varices

119 (39)

26 (33)

31 (36)

13 (38)

4 (13)

9 (30)

13 (38)

215 (36)

 Variceal bleeding

19 (6.3)

4 (5)

6 (6.9)

1 (2.9)

0 (0)

1 (3.3)

1 (2.9)

32 (5.4)

 Portal vein thrombosis

10 (3.3)

7 (8.8)

10 (11)

0 (0)

0 (0)

0 (0)

5 (15)

32 (5.4)

 Encephalopathy

34 (11)

5 (5)

2 (2.3)

1 (2.9)

0 (0)

2 (6.7)

0 (0)

43 (7.2)

 Spontaneous bacterial peritonitis

5 (1.7)

1 (1.3)

0 (0)

0 (0)

1 (3.2)

0 (0)

1 (2.9)

8 (1.3)

 Hepatocellular carcinoma

21 (6.9)

16 (20)

29 (33)

5 (15)

1 (3.2)

1 (3.3)

2 (5.9)

75 (13)

  1. AIH Autoimmune Hepatitis, HCV Hepatitis C, MELD Model for End-Stage Liver Disease, NAFLD Non-alcoholic Fatty Liver Disease, PBC Primary Biliary Cholangitis
  2. aObesity defined as body mass index > 30 kg/m2
  3. bMELD-score and Child Pugh-score calculated for 95% of patients